Saba Ilkhani
Impact in
-
- Sperm and Testicular Function
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
- Co-authors
- Pooria Nakhaei (6 shared papers)Mina Sarani (1 shared paper)Mohammad Amin Jadidi Kouhbanani (1 shared paper)Nasrin Beheshtkhoo (1 shared paper)Ali Mohammad Amani (1 shared paper)Siavash Shariatzadeh (3 shared papers)Mobina Amanollahi (4 shared papers)Mohsen Norouzian (1 shared paper)
- Journals
- The Journal of Trauma: Injury, Infection, and Critical Care (5 papers)The American Journal of Surgery (2 papers)Surgery (2 papers)Journal of the American College of Surgeons (2 papers)European Heart Journal (1 paper)
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Saba Ilkhani
34 papers receiving 245 citations
Peers
Comparison fields: 5 of 83
- Reproductive Medicine 18
- Biomaterials 23
- Emergency Medicine 12
- Immunology 25
- Oncology 30
Countries citing papers authored by Saba Ilkhani
This map shows the geographic impact of Saba Ilkhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saba Ilkhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saba Ilkhani more than expected).
Fields of papers citing papers by Saba Ilkhani
This network shows the impact of papers produced by Saba Ilkhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saba Ilkhani. The network helps show where Saba Ilkhani may publish in the future.
Co-authors
The 25 scholars most cited alongside Saba Ilkhani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 37 | |
| 2 | 2022 | 26 | |
| 3 | 2022 | 26 | |
| 4 | 2020 | 25 | |
| 5 | 2023 | 21 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 15 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2024 | 5 | |
| 15 | 2025 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2020 | 2 |
About Saba Ilkhani
Saba Ilkhani is a scholar working on Oncology, Infectious Diseases, Surgery, Pulmonary and Respiratory Medicine and Neurology, having authored 41 papers that have together received 253 indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers), Trauma and Emergency Care Studies (3 papers), Bacterial Infections and Vaccines (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). The work is most often cited by research in Reproductive Medicine (18 citations), Biomaterials (23 citations), Emergency Medicine (12 citations), Immunology (25 citations) and Oncology (30 citations). Saba Ilkhani has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Pooria Nakhaei, Mina Sarani, Mohammad Amin Jadidi Kouhbanani, Nasrin Beheshtkhoo, Ali Mohammad Amani, Siavash Shariatzadeh, Mobina Amanollahi, Mohsen Norouzian, Ali Moradi and Mehran Rahimlou. Their work appears in journals such as The Journal of Trauma: Injury, Infection, and Critical Care, The American Journal of Surgery, Surgery, Journal of the American College of Surgeons and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.